Integra Holdings

Venture Capital -, Israel Est. 2012
Visit website ↗ LinkedIn
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

Integra Holdings is a healthcare investment company with an exclusive first right to examine the innovations and intellectual property emerging from the world-renowned Hebrew University of Jerusalem. With a focus on biopharmaceuticals and medical diagnostics and devices, Integra employs multidisciplinary teams of experts who work alongside inventors and take a hands-on approach to achieve commercial success. Integra provides know-how and support to its portfolio companies from inception to commercialization, while leveraging its extensive industry network cultivated over decades of experience. The company holds a diversified portfolio of companies in the early to late stages, with established partnerships with investment funds such as OrbiMed, Pontifax, Lundbeck fund, SR One, CBI, and BioLight Life Sciences, as well as networks of private investors. Integra Holdings was founded by Yissum, the technology transfer company of the Hebrew University of Jerusalem. Its shareholders include Yissum, Temasek, Invatech Holdings, Arie Capital, Guangxi Wuzhou Pharmaceutical Group Co Ltd, and Israeli Institutional funds, including the Israeli Teachers and Kindergarten Study funds, the Hebrew University Provident Fund, and Halman-Aldubi Investment Group.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Integra Holdings' primary investment focus?
Integra Holdings is a healthcare investment company with a primary focus on biopharmaceuticals, medical diagnostics, and medical devices.
What is Integra Holdings' relationship with the Hebrew University of Jerusalem?
Integra Holdings was founded by Yissum, the technology transfer company of the Hebrew University of Jerusalem, and has an exclusive first right to examine innovations and intellectual property emerging from the university.
Which notable companies are in Integra Holdings' portfolio?
Integra Holdings' portfolio includes companies such as SpliSense, which received a $12 million investment in April 2024, and Atox Bio, which received a $30 million investment in December 2017.
When was Integra Holdings founded and where is it headquartered?
Integra Holdings was founded in 2012 and is headquartered in Tel Aviv-Yafo, Israel.
Has Integra Holdings raised external funds?
Yes, Integra Holdings raised $25 million in September 2017 and closed a $3 million investment from Guangxi Wuzhou Pharmaceutical Group in December 2014.
What is Integra Holdings' approach to supporting its portfolio companies?
Integra Holdings provides know-how and support from inception to commercialization, employing multidisciplinary teams and leveraging an extensive industry network.
Who are the shareholders of Integra Holdings?
Integra Holdings' shareholders include Yissum, Temasek, Invatech Holdings, Arie Capital, Guangxi Wuzhou Pharmaceutical Group Co Ltd, and Israeli institutional funds such as the Israeli Teachers and Kindergarten Study funds.
What is Integra Holdings' most recent investment activity?
Integra Holdings' most recent investment was $12 million into SpliSense in April 2024.